Latest Alzheimer's disease Stories
Study reveals preliminary evidence of target engagement of PKCe which the company believes is critical to improving cognitive function NEWARK, N.J., March 17, 2015 /PRNewswire/
NEW BRUNSWICK, N.J., March 17, 2015 /PRNewswire/ -- Johnson & Johnson (NYSE:JNJ) today announced that its Janssen Pharmaceutical Companies will invest $10 million in a new UK government-led
Collaboration Key to Beating the Disease, Stamping Out Stigma TORONTO, March 16, 2015 /CNW/ - The Alzheimer Society of Canada is taking part in the First WHO Ministerial Conference
CAMBRIDGE, Mass., March 16, 2015 /PRNewswire/ -- NeuroPhage Pharmaceuticals, Inc., today announced that Richard Fisher, PhD, the Company's Chief Scientific Officer, will present at the 12(th)
GENEVA, March 16, 2015 /PRNewswire/ -- The world's neurodegenerative disease specialists are gathering March 18-22, 2015 in Nice, France at the premier showcase for the
In what is being hailed as a breakthrough in Alzheimer’s research, a team of scientists at the University of Queensland's Queensland Brain Institute successfully restored memory function in mice using a non-invasive ultrasound technique.
First and only clinical trial to reduce hippocampal overactivity during aMCI, the pre-dementia stage of Alzheimer's disease BALTIMORE, March 11, 2015 /PRNewswire/ --
Challenge is Powered by Women's Brains and Championed by Influential Alzheimer's Advocates Including Maria Carrillo, Senator Susan Collins, Meryl Comer, Leeza Gibbons, Senator Barbara Mikulski, Ai-jen
SAN DIEGO, March 10, 2015 /PRNewswire/ -- ArmaGen Technologies (Calabasas, CA), a privately held biotechnology company focused on developing revolutionary therapies to treat severe neurological
CHICAGO and NEW YORK and TORONTO and LONDON, March 5, 2015 /PRNewswire-USNewswire/ -- Together, leading funders of research in the U.S., Canada and U.K.
- An armed gangster.